Correlation of serum vascular endothelial growth factor with clinicopathological parameters in cervical cancer

BioScience Trends

Volumn 3, Issue 4, 2009, Pages 144-150

  Srivastava, Shruti ^a   Gupta, Abhilasha ^a   Agarwal, Girdhar G ^b   Natu, Shankar M ^a   Uma, Singh ^a   Goel, Madhumati M ^a   Srivastava, Anand N ^c  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b UNIVERSITY OF LUCKNOW   (India)

^c Era's Lucknow Medical College and Hospital   (India)

Author keywords

Cervical cancer stages; Prognostic markers; VEGF

Indexed keywords

CISPLATIN; TUMOR MARKER; VASCULOTROPIN A;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD; BRACHYTHERAPY; CANCER STAGING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INDIA; NONPARAMETRIC TEST; PATHOLOGY; STATISTICS; UTERINE CERVIX TUMOR;

ANALYSIS OF VARIANCE; BRACHYTHERAPY; CISPLATIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INDIA; NEOPLASM STAGING; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77952561234     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Das BC, Gopalkrishna V, Hedau S, Sanjay K. Cancer of the uterine cervix and human Papilloma virus infection. Curr Sci. 2000; 78:52-63.
2. Misra JS, Srivastava S, Singh U, Srivastava AN. Riskfactors and strategies for control of carcinoma cervix in India: Hospital based cytological screening experience of 35 years. Indian J Cancer. 2009; 46:155-159.
3. Gajalakmi CK, Krishnamurthi S, Ananth R, Shanta V. Cervical cancer screening in Tamilnadu, India: A feasibility study of training the village health nurse. Cancer Causes Control. 1996; 7:520-524.
4. Zusterzeel PL, Span PN, Dijksterhuis MG, Thomas CM, Sweep FC, Massuger LF. Serum vascular endothelial growth factor: a prognostic factor in cervical cancer. J Cancer Res Clin Oncol. 2009; 135:283-290.
5. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990; 82:4-6.
6. Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat. 1995; 36:127-137.
7. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992; 267:10931-10934.
8. Cheng WF, Chen CA, Lee CN, Wei LH, Hsieh FJ, Hsieh CY. Vascular endothelial growth factor and prognosis of cervical carcinoma. Obstet Gynecol. 2000; 96:721-726.
9. Fujimoto J, Ichigo S, Hori M, Hirose R, Sakaguchi H, Tamaya T. Expression of basic fibroblast growth factor and its mRNA in advanced uterine cervical cancers. Cancer Lett. 1997; 111:21-26.
10. Fujimoto J, Sakaguchi H, Hirose R, Ichigo S, Tamaya T Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers. Br J Cancer. 1999; 80:827-833.
11. Jurgen D, Steffi P, Gabriele H, Ingrid H, Christine L, Axel B. Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients does anemia stimulate angiogenesis? Strahlenther Onkol. 1999; 175:93-96.
12. Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K. Regulation of angiogenesis via vascular endothelial growth factors. Cancer Res. 2000; 60:203-212.
13. Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat. 1995; 36:127-137.
14. Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Aalloum RM. Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionising radiation. Cancer Res. 1999; 59:3374-3378.
15. Guidi AJ, Abu-Jawdeh G, Berse B, Jackman RW, Tognazzi K, Dvorak HF, Brown LF. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst. 1995; 87:1237-1245.
16. Loncaster JA, Cooper RA, Logue JP, Davidson SE, Hunter RD, West CM. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. Br J Cancer. 2000; 83:620-625.
17. Tjalma W, Weyler J, Weyn B, Van Marck E, Van Daele A, Van Dam P. The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2000; 92:251-257.
18. Ugurel S, Rappl G, Tilgen W, Reinhold U. Increased serum concentration of angiogenic factor in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol. 2001; 19:577-583.
19. Adams J, Carder PJ, Downey S, Forbes MA, MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Walker JJ, Cairnduff F, Selby PJ, Perren TJ, Lansdown M, Banks RE. Vascular endothelial growth factor (VEGF) in breast cancer: comparision of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res. 2000; 60:2898-2905.
20. Hefler L, Tempfer C, Obermair A, Frischmuth K, Slintz G, Reinthaner A. Serum concentrations of vascular endothelial growth factor in vulvar cancer. Clin Cancer Res. 1999; 5:2806-2809.
21. Tempfer C, Obermair A, Hefler L, Haeusler G, Gitsch G, Kainz C. Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet Gynecol. 1998; 92:360-363.
22. Dobbs SP, Hewett PW, Johnson IR, Carmichael J, Murray JC. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br J Cancer. 1997; 76:1410-1415.
23. Lee IJ, Park KR, Lee KK, Song JS, Lee KG, Lee JY. Prognostic value of vascular endothelial growth factor in stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 2002; 54:768-779.
24. Moon HS, Kim SC, Ahn JJ, Woo BH. Concentration of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1) in the serum of patients with cervical cancer:prediction of response. Int J Gynecol Cancer. 2000; 10:151-156.
25. Yang YC, Wang KL, Su TH, Liao HF, Wu MH, Chen TC. Concurrent cisplatin-based chemoradiation for cervical carcinoma: tumor response, toxicity, and serum cytokine pro Wles. Cancer Invest. 2006; 24:390-395.
26. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997; 18:4-25.
27. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N. Tumor induction of VEGF promoter activity in stromal cells. Cell. 1998; 94:715-725.
28. Salven P, Teerenhovi L, Joensuu H. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood. 1997; 90:3167-3172.
29. Uchida S, Shimada Y, Watanabe G, Tanaka H, Shibagaki I, Miyahara T, Ishigami S, Imamura M. Oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutations, advanced stage and poor prognosis. Br J Cancer. 1998; 77:1704-1709.
30. Ishigami SI, Arii S, Furutani M, Niwano M, Harada T, Mizumoto M, Mori A, Onodera H, Imamura M. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of humancolorectal cancer. Br J Cancer. 1998; 78:1379-1384.
31. Chin KF, Greenman J, Gardiner E, Kumar H, Topping K, Monson J. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer. Br J Cancer. 2000; 83:1425-1431.
32. Linderholm B, Tavelin B, Gankvist K, Henriksson R. Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated nodenegative breast cancer. Br J Cancer. 1999; 81:727-732.
33. Mineta H, Miura K, Ogino T, Takebayashi S, Misawa K, Ueda Y, Suzuki I, Dictor M, Borg A, Wennerberg J. Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer. 2000; 86:775-781.
34. Fontanini G, Boldrini L, Chine S, Pisaturo F, Basalo F, Calcinai A, Lucchi M, Mussi A, Angeletti CA, Bevilacqua G. Expression of vascular endothelial growth factor mRNA in non-small cell lung carcinomas. Br J Cancer. 1999; 79:363-369.
35. Obermair A, Wanner C, Bilgi S, Speiser P, Kaider A, Reinthaller A. Tumor angiogenesis in stage IB cervical cancer: correlationof microvessel density with survival. Am J Obstet Gynecol. 1998; 178:314-319.
36. Tokumo K, Kodama J, Seki N, Nakanishi Y, Miyagi Y, Kamimura S, Yoshinouchi M, Okuda H, Kudo T. Different angiogenic pathways in human cervical cancers. Gynecol Oncol. 1998; 68:38-44.
37. Kodama J, Seki N, Tokumo K, Hongo A, Miyagi Y, Yoshinouchi M, Okuda H, Kudo T. Vascular endothelail growth factor is implicated in early invasion in cervical cancver. Eur J Cancer. 1999; 35:485-489
38. Jacobson J, Rasmuson T, Grankvist K, Ljungberg B. Vascular endothelial growth factor as prognostic factor in renal carcinoma. J Urol. 2000; 163:343-347.
39. Lebrecht A, Ludwig E, Huber A, Klein M, Schneeberger C, Tempfer C, Koelbl H, Hefler L. Serum vascular endothelial growth factor and serum leptin in patients with cervical cancer. Gynecol Oncol. 2002; 85:32-35.
40. Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K, Sekiya S. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer. 2005; 103:724-730.
41. Motulsky. Harvey Intuitive Biostatistics. Oxford University Press. Chapter 12. Interpreting insignificant P values. 1995.
42. Daya S. Understanding Clinical Research III. Statistical Inference. J SOGC. 1963; 181-191.